Trials / Completed
CompletedNCT00647244
Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients
Efficacy and Safety of Switching From AZT to Tenofovir
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Aarhus University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of switching from Retrovir to Tenofovir or Abacavir in HIV-infected patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tenofovir disoproxil fumarate | Tenofovir disoproxil 245 mg oral tablet once daily |
| DRUG | Abacavir | Abacavir 300 mg oral tablet twice daily |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2008-03-31
- Last updated
- 2010-12-20
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00647244. Inclusion in this directory is not an endorsement.